DK0698606T3 - Azolylaminderivat - Google Patents

Azolylaminderivat

Info

Publication number
DK0698606T3
DK0698606T3 DK94914585T DK94914585T DK0698606T3 DK 0698606 T3 DK0698606 T3 DK 0698606T3 DK 94914585 T DK94914585 T DK 94914585T DK 94914585 T DK94914585 T DK 94914585T DK 0698606 T3 DK0698606 T3 DK 0698606T3
Authority
DK
Denmark
Prior art keywords
azolylamine
derivatives
acid
addition salt
chem
Prior art date
Application number
DK94914585T
Other languages
English (en)
Inventor
Haruhito Chuo Kenkyu Kobayashi
Kiyoshi Chuo Kenkyusho K Nagai
Takanobu Chuo Kenkyusho Naito
Tokiko Chuo Kenkyusho Nishida
Hironobu Chuo Kenkyusho Ogura
Satoko Chuo Kenkyusho K Shusse
Mamoru Chuo Kenkyusho Ka Yokoo
Tadashi Chuo Kenkyusho K Arika
Original Assignee
Kaken Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharma Co Ltd filed Critical Kaken Pharma Co Ltd
Application granted granted Critical
Publication of DK0698606T3 publication Critical patent/DK0698606T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerization Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK94914585T 1993-05-10 1994-05-02 Azolylaminderivat DK0698606T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13293193 1993-05-10
PCT/JP1994/000737 WO1994026734A1 (en) 1993-05-10 1994-05-02 Azolylamine derivative

Publications (1)

Publication Number Publication Date
DK0698606T3 true DK0698606T3 (da) 1998-08-24

Family

ID=15092851

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94914585T DK0698606T3 (da) 1993-05-10 1994-05-02 Azolylaminderivat

Country Status (15)

Country Link
US (3) US5620994A (da)
EP (1) EP0698606B1 (da)
KR (1) KR100339166B1 (da)
CN (1) CN1046278C (da)
AT (1) ATE161257T1 (da)
AU (1) AU685116B2 (da)
CA (1) CA2162463C (da)
DE (1) DE69407409T2 (da)
DK (1) DK0698606T3 (da)
ES (1) ES2110749T3 (da)
GR (1) GR3025715T3 (da)
HU (1) HU225416B1 (da)
TW (1) TW325473B (da)
UA (1) UA41365C2 (da)
WO (1) WO1994026734A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2110749T3 (es) * 1993-05-10 1998-02-16 Kaken Pharma Co Ltd Derivado de azolilamina.
CN1125814C (zh) * 1995-09-28 2003-10-29 科研制药株式会社 4-亚甲基哌啶的制备方法
CA2391274C (en) * 1999-07-28 2010-12-14 Kaken Pharmaceutical Co., Ltd. Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating effect of antimicrobial agent, and antimicrobial agent
US20100080869A1 (en) * 2004-05-25 2010-04-01 Watson James B Live Bacteria product
US20090162419A1 (en) * 2004-05-25 2009-06-25 Watson James B Live bacteria product
US20090162481A1 (en) * 2004-05-25 2009-06-25 Watson James B Live bacteria product
WO2007101204A1 (en) * 2006-02-27 2007-09-07 Alcon Research, Ltd. Method of treating glaucoma
JP5372523B2 (ja) * 2006-12-28 2013-12-18 科研製薬株式会社 真菌症治療用ゲル組成物
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
JP5852573B2 (ja) 2010-08-31 2016-02-03 科研製薬株式会社 1−トリアゾール−2−ブタノール誘導体の製造法
AU2014329421B2 (en) 2013-10-03 2018-08-02 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
WO2015077729A2 (en) 2013-11-22 2015-05-28 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices
CN104292214B (zh) * 2014-09-24 2017-04-05 南京华威医药科技开发有限公司 艾氟康唑及其中间体的合成方法
CN104327047B (zh) * 2014-10-17 2016-04-06 苏州明锐医药科技有限公司 艾菲康唑的制备方法
CA2910990C (en) 2014-11-23 2022-03-22 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of efinaconazole
CA2974180A1 (en) * 2015-01-20 2016-07-28 Itai Adin Crystalline forms of efinaconazole
ITUB20150417A1 (it) 2015-05-08 2016-11-08 Dipharma Francis Srl Procedimento per la preparazione di composti piperidinici
US10479776B2 (en) 2015-05-12 2019-11-19 Lupin Limited Process for the preparation of Efinaconazole
EP3112360A1 (en) 2015-06-29 2017-01-04 Dipharma Francis S.r.l. Process for the preparation of efinaconazole
CN106565672A (zh) * 2015-10-08 2017-04-19 中美华世通生物医药科技(武汉)有限公司 制备艾氟康唑的方法
US20170129874A1 (en) * 2015-11-10 2017-05-11 Virupaksha Organics Limited Novel improved process for preparing a triazole antifungal agent
CN106810534A (zh) * 2015-11-30 2017-06-09 中美华世通生物医药科技(武汉)有限公司 艾氟康唑晶型及其制备方法
CN106928186A (zh) * 2015-12-29 2017-07-07 中美华世通生物医药科技(武汉)有限公司 化合物及其制备方法和用途
ITUB20159795A1 (it) 2015-12-30 2017-06-30 Procos Spa Processo per la sintesi di efinaconazolo
ITUA20162545A1 (it) 2016-04-13 2017-10-13 Laboratorio Chimico Int S P A Procedimento per la preparazione di intermedi utili nella sintesi di farmaci
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
IT201700048270A1 (it) 2017-05-04 2018-11-04 Seegpharm Sa Procedimento per la preparazione di un derivato azolico.
ES2941251T3 (es) 2017-05-19 2023-05-19 Kaken Pharma Co Ltd Métodos de producción y purificación de efinaconazol
CN110997646B (zh) 2017-08-10 2023-06-20 住友化学株式会社 环氧醇化合物的制造方法
WO2020133411A1 (zh) * 2018-12-29 2020-07-02 山东威智医药工业有限公司 一种艾氟康唑的制备方法
JP2021054781A (ja) 2019-09-26 2021-04-08 デボン エルエス,リミテッド 共結晶形エフィナコナゾール、及びその製造方法
KR102301743B1 (ko) 2020-12-29 2021-09-13 대봉엘에스 주식회사 에피나코나졸 경구용 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1162540A (en) * 1980-12-24 1984-02-21 Ikutaro Saji Imidazolylpropanol compounds and their acid addition salts, and production and use thereof
US4507484A (en) * 1982-07-24 1985-03-26 Pfizer Inc. Triazole antifungal agents
GB8412750D0 (en) * 1984-05-18 1984-06-27 Ici Plc Heterocyclic compounds
ES2110749T3 (es) * 1993-05-10 1998-02-16 Kaken Pharma Co Ltd Derivado de azolilamina.

Also Published As

Publication number Publication date
ATE161257T1 (de) 1998-01-15
US5716969A (en) 1998-02-10
CA2162463A1 (en) 1994-11-24
HU225416B1 (en) 2006-11-28
EP0698606A1 (en) 1996-02-28
WO1994026734A1 (en) 1994-11-24
EP0698606A4 (da) 1996-04-10
HUT75031A (en) 1997-03-28
CN1122598A (zh) 1996-05-15
US5962476A (en) 1999-10-05
AU685116B2 (en) 1998-01-15
CA2162463C (en) 2006-01-03
EP0698606B1 (en) 1997-12-17
HU9503217D0 (en) 1996-01-29
AU6689694A (en) 1994-12-12
DE69407409T2 (de) 1998-04-09
KR100339166B1 (ko) 2004-04-30
US5620994A (en) 1997-04-15
CN1046278C (zh) 1999-11-10
ES2110749T3 (es) 1998-02-16
TW325473B (en) 1998-01-21
UA41365C2 (uk) 2001-09-17
DE69407409D1 (de) 1998-01-29
GR3025715T3 (en) 1998-03-31

Similar Documents

Publication Publication Date Title
DK0698606T3 (da) Azolylaminderivat
AU5777490A (en) Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
BR9407169A (pt) Derivados de pirazol
AU9281198A (en) Benzofuran derivatives
ZA916268B (en) Tricyclic compound or salts thereof,method for producing the same and antimicrobial agent containing the same
ES2123873T3 (es) Pirrolocarbazol.
NO944371L (no) Kjemisk forbindelse med blodplateaggregeringsinhibiotoraktivitet
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
DE69326479D1 (de) Methotrexat-derivate
ITMI930819A1 (it) Derivati eterobiciclici ad attivita' fungicida